Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

850896-71-8

Etoricoxib D3

850896-71-8
59-06-3

Ethopabate

59-06-3
107724-20-9

Eplerenone

107724-20-9
142217-69-4

Entecavir

142217-69-4
114369-43-6

Fenbuconazole

114369-43-6
103361-09-7

Flumioxazine

103361-09-7
136426-54-5

Fluquinconazole

136426-54-5
42835-25-6

Flumequine

42835-25-6
42017-89-0

Fenofibric acid

42017-89-0
54739-18-3

Fluvoxamine

54739-18-3
49562-28-9

Fenofibrate

49562-28-9
98319-26-7

Finasteride

98319-26-7
59333-67-4

Fluoxetine HCl

59333-67-4
72479-26-6

Fenticonazole

72479-26-6
361377-29-9

Fluoxastrobin

361377-29-9
537-98-4

Ferulic acid

537-98-4
73231-34-2

Florfenicol

73231-34-2
75607-67-9

Fludarabine phosphate

75607-67-9
89429-59-4

Fluconazole Impurity A

89429-59-4
1622-62-4

Flunitrazepam

1622-62-4